In vivo, MYEOV knockdown reduced tumor invasion and metastasis, reduced expression signatures characteristic of the EMT, and reduced TGF-B signaling; constitutive activation of TGF-B signaling rescued these phenotypes. The gene discussed is TGFB1; the disease is neoplasm.